Odds Ratio | (95% CI) | P-value | |
---|---|---|---|
Year | 1.06 | (0.98;1.14) | 0.13 |
Country | |||
US | 1.00 | ||
Europe | 0.96 | (0.45;2.06) | 0.92 |
Other | 0.99 | (0.35;2.80) | 0.99 |
Age group | |||
Excludes < 65y | 1.00 | ||
Includes < 65y | 0.80 | (0.40;1.60) | 0.53 |
Study design | |||
Cross-sectional | 1.00 | ||
Cohort | 0.60 | (0.27;1.33) | 0.21 |
Sample size | 1.00 | (0.99;1.00) | 0.25 |
Cognitive outcome count | 1.03 | (0.54;1.98) | 0.92 |
Cognitive outcome type | |||
AD/dementia/impairment | 1.00 | ||
Cognitive function/decline | 1.52 | (0.72;3.22) | 0.27 |
Both | 1.78 | (0.16;19.7) | 0.64 |
Risk factor | |||
EDU | 1.00 | ||
SMOK | 0.21 | (0.06;0.70) | 0.012 |
ALCO | 0.33 | (0.08;1.29) | 0.11 |
PA | 2.49 | (0.26;24.29) | 0.43 |
CAFF | 0.18 | (0.04;0.84) | 0.029 |
ANTIOX | 0.20 | (0.06;0.75) | 0.016 |
HCY | 0.41 | (0.10;1.67) | 0.22 |
N-3 FA | 0.25 | (0.06;1.05) | 0.06 |